The International thoracic organ transplant registry of the international society for heart and lung transplantation: Thirty-ninth adult heart transplantation report-2022; focus on transplant for restrictive heart disease.

Abstract

This 39th annual international adult heart transplant report focuses on transplantation for heart disease with restrictive physiology, that is, restrictive cardiomyopathies and hypertrophic cardiomyopathy, based on data submitted to the International Society for Heart and Lung Transplantation (ISHLT) Thoracic Organ Transplant (TTX) Registry between January 1992 and June 2018. Restrictive cardiomyopathy (RCM) refers to a heterogeneous group of cardiomyopathies that includes amyloid, sarcoid, radiation and/or chemotherapy-induced cardiomyopathy, and other types of heart disease that all share restrictive physiology, and reduced or normal diastolic and systolic volumes in 1 or both ventricles.